Oncomed Pharma
(OMED)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,101 | -3,435 | -9,550 | -5,574 | -39,062 |
| Depreciation Amortization | 1,691 | 1,288 | 853 | 423 | 1,710 |
| Accounts receivable | -19 | -11 | 295 | 147 | 2,110 |
| Accounts payable and accrued liabilities | -778 | 598 | -1,584 | -1,861 | -2,325 |
| Other Working Capital | -45,294 | -35,006 | -18,051 | -11,529 | -57,032 |
| Other Operating Activity | 7,639 | 5,115 | 5,399 | 3,992 | 9,629 |
| Operating Cash Flow | $-44,862 | $-31,451 | $-22,638 | $-14,402 | $-84,970 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 41,837 | 27,013 | 20,163 | 15,381 | 57,835 |
| PPE Investments | -655 | -522 | -283 | -172 | -585 |
| Investing Cash Flow | $41,182 | $26,491 | $19,880 | $15,209 | $57,250 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 89 | 89 | 42 | 41 | 4,044 |
| Financing Cash Flow | $89 | $89 | $42 | $41 | $4,044 |
| Beginning Cash Position | 13,277 | 13,277 | 13,277 | 13,277 | 36,953 |
| End Cash Position | 9,686 | 8,406 | 10,561 | 14,125 | 13,277 |
| Net Cash Flow | $-3,591 | $-4,871 | $-2,716 | $848 | $-23,676 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,862 | -31,451 | -22,638 | -14,402 | -84,970 |
| Capital Expenditure | -655 | -522 | -283 | -172 | -585 |
| Free Cash Flow | -45,517 | -31,973 | -22,921 | -14,574 | -85,555 |